James Black, MD
Cardiovascular Disease · Austin, TXNPI 1831159789
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,585 of the $3,285 with a category attached, or 78.7%. Medtronic accounts for 80.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $1,644 and has fallen 89.1% since, to $180 in 2022. That places this record below the midpoint for cardiovascular disease clinicians in TX, where the typical reported total is $3,258.
Across 22 payments — averaging $149.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$449
- Boston Scientific$129
- Heartflow, Inc.$50
- E.r. Squibb & Sons, L.L.C.$22
Across 2 payments — averaging $355.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$710
What the payments were for
- Travel & lodging$2,58579%
- Food & beverage$70021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 14 | $2,635 |
| Abbott | 5 | $449 |
| Boston Scientific | 1 | $129 |
| Heartflow, Inc. | 1 | $50 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,151
- Arctic Front$1,085
- Ensite Cardiac Mapping System$315
- GENERAL - THERAPIES$129
How this compares
$3,285 in reported general payments places this provider in the 50th percentile of 1,515 cardiovascular disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 191 | $200,901 |
| XareltoRivaroxaban | 57 | $71,041 |
| MultaqDronedarone Hcl | 40 | $46,576 |
| Repatha SureclickEvolocumab | 18 | $27,892 |
| EntrestoSacubitril/Valsartan | 19 | $17,840 |
| CorlanorIvabradine Hcl | 12 | $6,972 |
| Metoprolol Succinate | 269 | $3,785 |
| Flecainide Acetate | 77 | $2,824 |
| Losartan Potassium | 74 | $922 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 38 | $860 |
| Rosuvastatin Calcium | 93 | $758 |
| Diltiazem 24hr Er (Xr)Diltiazem Hcl | 13 | $655 |
| SotalolSotalol Hcl | 36 | $604 |
| Ramelteon | 12 | $457 |
| Lisinopril | 55 | $452 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Austin
- Vivek GoswamiAustin$322K
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
- Amarinder BindraDallas$512K
- Robert SalazarKingwood$478K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.